BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/25/2022 9:22:03 AM | Browse: 394 | Download: 441
 |
Received |
|
2021-04-30 17:56 |
|
Peer-Review Started |
|
2021-04-30 17:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-30 06:04 |
|
Revised |
|
2021-07-14 16:15 |
|
Second Decision |
|
2022-01-15 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-01-17 05:29 |
|
Articles in Press |
|
2022-01-17 05:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-01-14 02:21 |
|
Typeset the Manuscript |
|
2022-01-24 02:55 |
|
Publish the Manuscript Online |
|
2022-01-25 09:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Viral hepatitis: Innovations and expectations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Simona Leoni, Alberto Casabianca, Benedetta Biagioni and Ilaria Serio |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Simona Leoni, MD, PhD, Doctor, Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna 40138, Italy. simona.leoni@aosp.bo.it |
| Key Words |
Viral hepatitis; Chronic liver disease; Treatments; Antiviral; Immunotherapy; Vaccination |
| Core Tip |
Viral hepatitis is a known worldwide health problem, with a risk of evolution in chronic liver disease. Novel therapies have shown increased efficacy in curing the hepatitis C virus (HCV), with the goal of HCV elimination by 2030. New concurrent interest in hepatitis B virus (HBV) curative therapies has been recently registered: New antivirals targeting different steps of HBV life cycle and immune modulators. In hepatitis D, the improved knowledge of the life cycle has facilitated the development of some direct-acting agents, more effective than interferon-based therapies. New studies are required to improve the treatment of hepatitis E. |
| Publish Date |
2022-01-25 09:22 |
| Citation |
Leoni S, Casabianca A, Biagioni B, Serio I. Viral hepatitis: Innovations and expectations. World J Gastroenterol 2022; 28(5): 517-531 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i5/517.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i5.517 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
